Subscribe To
TRACON Pharmaceuticals Announces Arbitration Award in Dispute with I-Mab
SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost-efficient, CRO-independent product development platform to advance its pipeline of novel targeted cancer therapeutics and to partner with other life science companies, today announced that the tribunal in the arbitration against I-Mab conducted under the […] The post TRACON Pharmaceuticals Announces Arbitration Award in Dispute with I-Mab appeared...
Read More
Posted: Apr 25 2023, 11:41
Author Name: forextv
Views: 110723